• 名称: HCC202(人乳腺原发性导管癌)
  • 货号: CBP60416
  • 浏览次数: 244
  • 已销售数量:0件
  • 评论信息
  • 购买数量:  购买数量不能低于最少订购数量!

购买 询价 收藏 QQ交流 好友推荐

CBP60416
I. General information 
Synonyms: HCC202
Background: The HCC202 cell line was initiated from a primary ductal carcinoma on September 5, 1992, and took 41 months to establish.
Species: Homo sapiens, human
Tissue: breast; mammary gland/duct
Disease: TNM stage IIIA, grade 3, primary ductal carcinoma
Gender: female, Caucasian, White, 82 years
Morphology: epithelial
Growth Mode: adherent, The line grows as attached medium-sized epithelial cells with some floating cells
Doubling Time: N/A
DNA Profile: Amelogenin: X
CSF1PO: 10
D13S317: 8,9
D16S539: 13
D5S818: 11,13
D7S820: 8,12
THO1: 6
TPOX: 8,9
vWA: 16
Cobioer’s Cell Line Authentication Service
Culture Medium: RPMI-1640+10%FBS
We strongly suggest to purchase the complete medium from Cobioer.
Cryopreservation medium: 90%FBS+10%DMSO
Antigen Expression: N/A
Receptor Expression: estrogen receptor, negative
progesterone receptor, negative
Oncogene: her2/neu +, p53 -
Genes Expressed: Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
Cellular Products: Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
Tumor Formation: N/A
Comments: The tumor was classified as TNM Stage IIIA, grade 3, invasive ductal carcinoma with metastases in 4 out of 19 lymph nodes.
The cells are poorly differentiated.
The cells are positive for expression of Her2-neu, but are negative for expression of p53.
HCC202 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2) and for cytokeratin 19.
The cells are negative for expression of estrogen receptor (ER -) and progesterone receptor (PR -).
For more information, please contact Cobioer (4008-750-250).

关键词: